TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.

Ito Y, Shimono J, Kawamoto K, Hatanaka KC, Kogure Y, Tabata M, Saito Y, Mizuno K, Horie S, Mizukami Y, Koya J, Murakami K, Teshima T, Hatanaka Y, Chiba K, Okada A, Shiraishi Y, Miyoshi H, Matsuno Y, Ohshima K, Kataoka K, Nakagawa M

Open source

DOI
10.1038/s41375-025-02631-5
Published
2025 Jul
Container
Leukemia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41375-025-02631-5,
  title = {TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.},
  author = {Ito Y and Shimono J and Kawamoto K and Hatanaka KC and Kogure Y and Tabata M and Saito Y and Mizuno K and Horie S and Mizukami Y and Koya J and Murakami K and Teshima T and Hatanaka Y and Chiba K and Okada A and Shiraishi Y and Miyoshi H and Matsuno Y and Ohshima K and Kataoka K and Nakagawa M},
  year = {2025},
  journal = {Leukemia},
  doi = {10.1038/s41375-025-02631-5},
  url = {https://doi.org/10.1038/s41375-025-02631-5}
}

RIS

TY  - JOUR
TI  - TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.
AU  - Ito Y
AU  - Shimono J
AU  - Kawamoto K
AU  - Hatanaka KC
AU  - Kogure Y
AU  - Tabata M
AU  - Saito Y
AU  - Mizuno K
AU  - Horie S
AU  - Mizukami Y
AU  - Koya J
AU  - Murakami K
AU  - Teshima T
AU  - Hatanaka Y
AU  - Chiba K
AU  - Okada A
AU  - Shiraishi Y
AU  - Miyoshi H
AU  - Matsuno Y
AU  - Ohshima K
AU  - Kataoka K
AU  - Nakagawa M
PY  - 2025
JO  - Leukemia
DO  - 10.1038/s41375-025-02631-5
UR  - https://doi.org/10.1038/s41375-025-02631-5
ER  - 

APA

Y, I., J, S., K, K., KC, H., Y, K., M, T., Y, S., K, M., S, H., Y, M., J, K., K, M., T, T., Y, H., K, C., A, O., Y, S., H, M., Y, M., K, O., K, K., & M, N. (2025). TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.. Leukemia. https://doi.org/10.1038/s41375-025-02631-5

Source records